Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus sevoflurane anesthesia for emergence agitation after laparoscopic gastric or colorectal cancer surgery
ChiCTR2500095670Phase 4Not yet recruiting
- Sponsor
- Jianyang People's Hospital
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in Emergence agitation (EA) comparing Remimazolam group with Sevoflurane group (2 arms). Primary endpoint: Incidence of emergence agitation. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
remimazolamsevoflurane
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2500095670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095670.